Cargando…

Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?

Next-generation sequencing (NGS) technologies and data have revolutionized cancer research and are increasingly being deployed to guide clinicians in treatment decision-making. NGS technologies have allowed us to take an “omics” approach to cancer in order to reveal genomic, transcriptomic, and epig...

Descripción completa

Detalles Bibliográficos
Autores principales: LeBlanc, Veronique G., Marra, Marco A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586802/
https://www.ncbi.nlm.nih.gov/pubmed/26404381
http://dx.doi.org/10.3390/cancers7030869
_version_ 1782392436999323648
author LeBlanc, Veronique G.
Marra, Marco A.
author_facet LeBlanc, Veronique G.
Marra, Marco A.
author_sort LeBlanc, Veronique G.
collection PubMed
description Next-generation sequencing (NGS) technologies and data have revolutionized cancer research and are increasingly being deployed to guide clinicians in treatment decision-making. NGS technologies have allowed us to take an “omics” approach to cancer in order to reveal genomic, transcriptomic, and epigenomic landscapes of individual malignancies. Integrative multi-platform analyses are increasingly used in large-scale projects that aim to fully characterize individual tumours as well as general cancer types and subtypes. In this review, we examine how NGS technologies in particular have contributed to “omics” approaches in cancer research, allowing for large-scale integrative analyses that consider hundreds of tumour samples. These types of studies have provided us with an unprecedented wealth of information, providing the background knowledge needed to make small-scale (including “N of 1”) studies informative and relevant. We also take a look at emerging opportunities provided by NGS and state-of-the-art third-generation sequencing technologies, particularly in the context of translational research. Cancer research and care are currently poised to experience significant progress catalyzed by accessible sequencing technologies that will benefit both clinical- and research-based efforts.
format Online
Article
Text
id pubmed-4586802
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-45868022015-10-06 Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us? LeBlanc, Veronique G. Marra, Marco A. Cancers (Basel) Review Next-generation sequencing (NGS) technologies and data have revolutionized cancer research and are increasingly being deployed to guide clinicians in treatment decision-making. NGS technologies have allowed us to take an “omics” approach to cancer in order to reveal genomic, transcriptomic, and epigenomic landscapes of individual malignancies. Integrative multi-platform analyses are increasingly used in large-scale projects that aim to fully characterize individual tumours as well as general cancer types and subtypes. In this review, we examine how NGS technologies in particular have contributed to “omics” approaches in cancer research, allowing for large-scale integrative analyses that consider hundreds of tumour samples. These types of studies have provided us with an unprecedented wealth of information, providing the background knowledge needed to make small-scale (including “N of 1”) studies informative and relevant. We also take a look at emerging opportunities provided by NGS and state-of-the-art third-generation sequencing technologies, particularly in the context of translational research. Cancer research and care are currently poised to experience significant progress catalyzed by accessible sequencing technologies that will benefit both clinical- and research-based efforts. MDPI 2015-09-23 /pmc/articles/PMC4586802/ /pubmed/26404381 http://dx.doi.org/10.3390/cancers7030869 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
LeBlanc, Veronique G.
Marra, Marco A.
Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
title Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
title_full Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
title_fullStr Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
title_full_unstemmed Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
title_short Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
title_sort next-generation sequencing approaches in cancer: where have they brought us and where will they take us?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586802/
https://www.ncbi.nlm.nih.gov/pubmed/26404381
http://dx.doi.org/10.3390/cancers7030869
work_keys_str_mv AT leblancveroniqueg nextgenerationsequencingapproachesincancerwherehavetheybroughtusandwherewilltheytakeus
AT marramarcoa nextgenerationsequencingapproachesincancerwherehavetheybroughtusandwherewilltheytakeus